Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine SR in Chronic Systolic Heart Failure (FIRST)
NCT02188082Phase 3Unknown
- Sponsor
- Hengrui
- Start
- May 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in chronic systolic heart failure (HFrEF), sponsored by Hengrui. Status: unknown.
02
Drugs
ivabradine
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT02188082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188082.